January 25, 2021
A New Jersey federal judge has said manufacturers, wholesalers and pharmacies cannot escape warranty claims in multidistrict litigation alleging they took part in distributing generic drugs containing the active ingredient valsartan that were tainted with carcinogens, finding that the drugs' names and the purported contamination kept certain claims alive.
January 12, 2021
A New Jersey federal judge said Tuesday that consumers in the multidistrict litigation over alleged contamination of the blood pressure drug valsartan don't have standing to bring claims under the laws of states they don't live in.
January 08, 2021
A New Jersey federal judge on Friday said that emails sent by Torrent Pharmaceuticals Ltd. to customers in the multidistrict litigation over alleged contamination of the blood pressure drug Valsartan are not confidential since they don't contain trade secrets.
January 04, 2021
A New Jersey federal judge on Monday appointed two former federal judges as special masters to oversee settlement negotiations in multidistrict litigation over alleged contamination of the blood pressure drug Valsartan.
December 18, 2020
A New Jersey federal judge won't let manufacturers, wholesalers and pharmacies escape multidistrict litigation over their alleged failure to keep contamination out of the blood pressure drug Valsartan, saying federal law doesn't preempt claims by buyers and users of the drug.
September 21, 2020
A class of consumers urged a New Jersey federal court to reject attempts by Walgreens, CVS and Rite Aid to escape multidistrict litigation alleging they misrepresented a generic high blood pressure drug, saying the pharmacies are shirking obligations by calling themselves drug testers instead of sellers.
July 20, 2020
Pharmacies including CVS and Walgreens have urged a New Jersey federal judge to drop them from multidistrict litigation alleging they misrepresented a generic high blood pressure drug, arguing that the allegations are barred by federal law and that all liability lies with the manufacturers, not the pharmacies.
February 27, 2020
A New Jersey federal magistrate judge Thursday rejected a second attempt by three attorneys to withdraw as counsel for two clients in multidistrict litigation over a contaminated blood pressure drug, saying they need to explain how they tried to get in contact with their unresponsive clients.
September 24, 2019
A recent opinion by a New Jersey federal judge in multidistrict litigation over a contaminated blood pressure drug further undercuts the use of speculative arguments about the risks of third-party legal financing and requirements for blanket disclosures, experts said.